Loading...

Nutrien

TSX:NTR
Snowflake Description

Adequate balance sheet with moderate growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
NTR
TSX
CA$43B
Market Cap
  1. Home
  2. CA
  3. Materials
Company description

Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. The last earnings update was 77 days ago. More info.


Add to Portfolio Compare Print
NTR Share Price and Events
7 Day Returns
0.9%
TSX:NTR
0.9%
CA Chemicals
0.6%
CA Market
1 Year Returns
21.9%
TSX:NTR
15.1%
CA Chemicals
3.4%
CA Market
NTR Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Nutrien (NTR) 0.9% 7.2% 6.7% 21.9% - -
CA Chemicals 0.9% 5.3% 5.6% 15.1% 51.9% -2.9%
CA Market 0.6% 2.7% 8.3% 3.4% 15.7% 7.1%
1 Year Return vs Industry and Market
  • NTR outperformed the Chemicals industry which returned 15.1% over the past year.
  • NTR outperformed the Market in Canada which returned 3.4% over the past year.
Price Volatility
Industry
5yr Volatility vs Market

NTR Value

 Is Nutrien undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Nutrien to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Nutrien.

TSX:NTR Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 18 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 10.6%
Perpetual Growth Rate 10-Year CA Government Bond Rate 1.9%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for TSX:NTR
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year CA Govt Bond Rate 1.9%
Equity Risk Premium S&P Global 6%
Chemicals Unlevered Beta Simply Wall St/ S&P Global 1.38
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 1.379 (1 + (1- 26.5%) (28.54%))
1.447
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.45
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.95% + (1.447 * 5.96%)
10.57%

Discounted Cash Flow Calculation for TSX:NTR using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Nutrien is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

TSX:NTR DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 10.57%)
2019 2,534.33 Analyst x9 2,291.99
2020 2,535.15 Analyst x11 2,073.49
2021 2,680.25 Analyst x4 1,982.53
2022 3,075.50 Analyst x2 2,057.36
2023 3,234.09 Est @ 5.16% 1,956.57
2024 3,369.72 Est @ 4.19% 1,843.68
2025 3,488.33 Est @ 3.52% 1,726.06
2026 3,594.65 Est @ 3.05% 1,608.59
2027 3,692.34 Est @ 2.72% 1,494.30
2028 3,784.14 Est @ 2.49% 1,385.01
Present value of next 10 years cash flows $18,419.57
TSX:NTR DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2028 × (1 + g) ÷ (Discount Rate – g)
= $3,784.14 × (1 + 1.95%) ÷ (10.57% – 1.95%)
$44,720.00
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $44,720.00 ÷ (1 + 10.57%)10
$16,367.67
TSX:NTR Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $18,419.57 + $16,367.67
$34,787.24
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $34,787.24 / 597.48
$58.22
TSX:NTR Discount to Share Price
Calculation Result
Exchange Rate USD/CAD
(Reporting currency to currency of TSX:NTR)
1.342
Value per Share
(CAD)
= Value per Share in USD x Exchange Rate (USD/CAD)
= $58.22 x 1.342
CA$78.14
Value per share (CAD) From above. CA$78.14
Current discount Discount to share price of CA$72.60
= -1 x (CA$72.60 - CA$78.14) / CA$78.14
7.1%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Nutrien is available for.
Intrinsic value
7%
Share price is CA$72.6 vs Future cash flow value of CA$78.14
Current Discount Checks
For Nutrien to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Nutrien's share price is below the future cash flow value, but not at a moderate discount (< 20%).
  • Nutrien's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Nutrien's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Nutrien's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
TSX:NTR PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-12-31) in USD $-0.05
TSX:NTR Share Price ** TSX (2019-04-23) in CAD CA$72.6
TSX:NTR Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.745 $54.09
Canada Chemicals Industry PE Ratio Median Figure of 5 Publicly-Listed Chemicals Companies 9.08x
Canada Market PE Ratio Median Figure of 557 Publicly-Listed Companies 14.88x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Nutrien.

TSX:NTR PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= TSX:NTR Share Price ÷ EPS (both in USD)

= 54.09 ÷ -0.05

-1090.44x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Nutrien is loss making, we can't compare its value to the CA Chemicals industry average.
  • Nutrien is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does Nutrien's expected growth come at a high price?
Raw Data
TSX:NTR PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -1090.44x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 18 Analysts
36.8%per year
North America Chemicals Industry PEG Ratio Median Figure of 50 Publicly-Listed Chemicals Companies 1.52x
Canada Market PEG Ratio Median Figure of 256 Publicly-Listed Companies 1.2x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Nutrien, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Nutrien's assets?
Raw Data
TSX:NTR PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-12-31) in USD $40.14
TSX:NTR Share Price * TSX (2019-04-23) in CAD CA$72.6
TSX:NTR Share Price converted to USD reporting currency Exchange rate (CAD/ USD) 0.745 $54.09
Canada Chemicals Industry PB Ratio Median Figure of 30 Publicly-Listed Chemicals Companies 1.34x
Canada Market PB Ratio Median Figure of 2,380 Publicly-Listed Companies 1.51x
TSX:NTR PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= TSX:NTR Share Price ÷ Book Value per Share (both in USD)

= 54.09 ÷ 40.14

1.35x

* Primary Listing of Nutrien.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Nutrien is overvalued based on assets compared to the CA Chemicals industry average.
X
Value checks
We assess Nutrien's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Chemicals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Chemicals industry average (and greater than 0)? (1 check)
  5. Nutrien has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

NTR Future Performance

 How is Nutrien expected to perform in the next 1 to 3 years based on estimates from 18 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
36.8%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Nutrien expected to grow at an attractive rate?
  • Nutrien's earnings growth is expected to exceed the low risk savings rate of 1.9%.
Growth vs Market Checks
  • Nutrien's earnings growth is expected to exceed the Canada market average.
  • Nutrien's revenue growth is positive but not above the Canada market average.
Annual Growth Rates Comparison
Raw Data
TSX:NTR Future Growth Rates Data Sources
Data Point Source Value (per year)
TSX:NTR Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 18 Analysts 36.8%
TSX:NTR Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 18 Analysts 4.1%
Canada Chemicals Industry Earnings Growth Rate Market Cap Weighted Average 29.4%
Canada Chemicals Industry Revenue Growth Rate Market Cap Weighted Average 3.2%
Canada Market Earnings Growth Rate Market Cap Weighted Average 18.2%
Canada Market Revenue Growth Rate Market Cap Weighted Average 7.2%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
TSX:NTR Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 18 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
TSX:NTR Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2022-12-31 21,839 4,277 2,238 1
2021-12-31 21,148 3,897 2,119 6
2020-12-31 20,797 3,841 1,984 14
2019-12-31 20,084 3,572 1,775 17
TSX:NTR Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-12-31 18,772 2,052 -31
2018-09-30 16,164 465 -447
2018-06-30 13,445 935 636
2018-03-31 6,518 662 47
2017-12-31 4,010 1,225 154
2017-09-30 3,973 1,197 196
2017-06-30 3,893 1,199 261
2017-03-31 3,824 1,295 230
2016-12-31 3,921 1,260 199
2016-09-30 4,239 1,530 478
2016-06-30 4,658 1,593 679
2016-03-31 5,330 2,005 975

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Nutrien's earnings are expected to grow significantly at over 20% yearly.
  • Nutrien's revenue is expected to grow by 4.1% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
TSX:NTR Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 18 Analyst Estimates (S&P Global) See Below

All data from Nutrien Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

TSX:NTR Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2022-12-31 3.78 3.78 3.78 1.00
2021-12-31 3.57 3.65 3.43 3.00
2020-12-31 3.42 3.86 3.15 8.00
2019-12-31 2.98 3.19 2.85 7.00
TSX:NTR Past Financials Data
Date (Data in USD Millions) EPS *
2018-12-31 -0.05
2018-09-30 -0.66
2018-06-30 0.86
2018-03-31 0.06
2017-12-31 0.18
2017-09-30 0.23
2017-06-30 0.31
2017-03-31 0.27
2016-12-31 0.24
2016-09-30 0.57
2016-06-30 0.81
2016-03-31 1.17

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Nutrien is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Nutrien's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Nutrien has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

NTR Past Performance

  How has Nutrien performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Nutrien's growth in the last year to its industry (Chemicals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Nutrien does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Nutrien's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Nutrien's 1-year growth to the North America Chemicals industry average as it is not currently profitable.
Earnings and Revenue History
Nutrien's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Nutrien Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

TSX:NTR Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-12-31 18,772.00 -31.00 2,876.00
2018-09-30 16,164.00 -447.00 2,298.00
2018-06-30 13,445.00 636.00 1,631.00
2018-03-31 6,518.00 47.00 834.00
2017-12-31 4,010.00 154.00 233.00
2017-09-30 3,973.00 196.00 218.00
2017-06-30 3,893.00 261.00 221.00
2017-03-31 3,824.00 230.00 233.00
2016-12-31 3,921.00 199.00 231.00
2016-09-30 4,239.00 478.00 253.00
2016-06-30 4,658.00 679.00 246.00
2016-03-31 5,330.00 975.00 251.00
2015-12-31 5,791.00 1,115.00 258.00
2015-09-30 6,303.00 1,476.00 258.00
2015-06-30 6,402.00 1,511.00 255.00
2015-03-31 6,529.00 1,566.00 250.00
2014-12-31 6,506.00 1,536.00 258.00
2014-09-30 6,152.00 1,359.00 255.00
2014-06-30 6,033.00 1,398.00 254.00
2014-03-31 6,296.00 1,569.00 250.00
2013-12-31 6,733.00 1,785.00 248.00
2013-09-30 6,858.00 1,976.00 218.00
2013-06-30 7,466.00 2,265.00 223.00
2013-03-31 7,742.00 2,144.00 228.00
2012-12-31 7,433.00 2,079.00 219.00
2012-09-30 7,683.00 2,341.00 207.00
2012-06-30 7,886.00 2,522.00 200.00

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Nutrien has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • Nutrien used its assets less efficiently than the CA Chemicals industry average last year based on Return on Assets.
  • It is difficult to establish if Nutrien improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Nutrien's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Chemicals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Nutrien has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

NTR Health

 How is Nutrien's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Nutrien's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Nutrien is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Nutrien's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Nutrien's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Nutrien Company Filings, last reported 3 months ago.

TSX:NTR Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-12-31 24,425.00 9,223.00 2,314.00
2018-09-30 22,035.00 13,366.00 1,902.00
2018-06-30 23,700.00 12,063.00 1,956.00
2018-03-31 23,431.00 10,706.00 460.00
2017-12-31 8,303.00 4,441.00 116.00
2017-09-30 8,513.00 4,494.00 97.00
2017-06-30 8,498.00 4,532.00 97.00
2017-03-31 8,308.00 4,612.00 62.00
2016-12-31 8,199.00 4,591.00 32.00
2016-09-30 8,048.00 4,750.00 153.00
2016-06-30 8,024.00 4,634.00 143.00
2016-03-31 8,286.00 4,564.00 74.00
2015-12-31 8,382.00 4,227.00 91.00
2015-09-30 8,589.00 4,123.00 73.00
2015-06-30 9,085.00 4,205.00 449.00
2015-03-31 8,929.00 4,204.00 217.00
2014-12-31 8,792.00 4,245.00 215.00
2014-09-30 8,760.00 4,192.00 152.00
2014-06-30 8,947.00 4,141.00 107.00
2014-03-31 9,371.00 4,205.00 533.00
2013-12-31 9,628.00 3,937.00 628.00
2013-09-30 9,934.00 3,578.00 555.00
2013-06-30 10,317.00 3,463.00 630.00
2013-03-31 10,442.00 4,048.00 585.00
2012-12-31 9,912.00 4,081.00 562.00
2012-09-30 9,576.00 4,038.00 461.00
2012-06-30 8,781.00 4,154.00 491.00
  • Nutrien's level of debt (37.8%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (40.9% vs 37.8% today).
  • Debt is well covered by operating cash flow (22.2%, greater than 20% of total debt).
  • Nutrien is making a loss, therefore interest payments are not well covered by earnings.
X
Financial health checks
We assess Nutrien's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Nutrien has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

NTR Dividends

 What is Nutrien's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
3.18%
Current annual income from Nutrien dividends. Estimated to be 3.33% next year.
If you bought CA$2,000 of Nutrien shares you are expected to receive CA$64 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Nutrien's pays a higher dividend yield than the bottom 25% of dividend payers in Canada (2.05%).
  • Nutrien's dividend is below the markets top 25% of dividend payers in Canada (5.51%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
TSX:NTR Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 18 Analyst Estimates (S&P Global) See Below
North America Chemicals Industry Average Dividend Yield Market Cap Weighted Average of 59 Stocks 2.5%
Canada Market Average Dividend Yield Market Cap Weighted Average of 331 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.2%
Canada Bottom 25% Dividend Yield 25th Percentile 2.1%
Canada Top 25% Dividend Yield 75th Percentile 5.5%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

TSX:NTR Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2022-12-31 1.72 1.00
2021-12-31 1.88 9.00
2020-12-31 1.82 16.00
2019-12-31 1.74 16.00
TSX:NTR Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2018-12-14 1.720 3.342
2018-11-07 1.720 3.334
2018-11-06 1.720 3.010
2018-11-05 1.720 3.088
2018-07-19 1.600 2.890
2018-05-24 1.600 3.038
2018-02-21 1.600 3.322
2018-02-05 0.000 0.000
2018-01-02 0.400 0.753

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • It is too early to tell whether Nutrien has stable dividend payments.
  • Nutrien only just started paying a dividend, it is too early to tell if payments are increasing.
Current Payout to shareholders
What portion of Nutrien's earnings are paid to the shareholders as a dividend.
  • The company is paying a dividend however it is incurring a loss.
Future Payout to shareholders
  • Dividends after 3 years are expected to be covered by earnings (1.9x coverage).
X
Income/ dividend checks
We assess Nutrien's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Nutrien afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Nutrien has a total score of 2/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

NTR Management

 What is the CEO of Nutrien's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Chuck Magro
COMPENSATION $12,889,855
AGE 48
TENURE AS CEO 1.8 years
CEO Bio

Mr. Charles Victor Magro, also known as Chuck, B.Sc. (Chem), MBA is President and Chief Executive Officer of Nutrien Ltd. since June 2, 2017. Mr. Magro served as President and Chief Executive Officer of Agrium Inc. since January 1, 2014 until 2017. His Key skills and experience includes: Mergers & Acquisitions, Strategy and Operations. He joined Agrium in November 2009 as Vice President of Manufacturing following a productive career with NOVA Chemicals, a major petrochemical manufacturer, most recently as Vice President of Investor Relations between 2007 and 2009. He was Executive Vice President, Chief Operating Officer, Executive Vice President, Corporate Development, Chief Risk Officer and Vice President at Agrium. He served as Director of Agrium from 2013 to 2018. He serves on the boards of Canpotex Limited, the Business Council of Canada, the International Fertilizer Association and the International Plant Nutrition Institute. He also serves as chair of The Fertilizer Institute and the Nutrients for Life Foundation. He serves as Executive Director of Nutrien Ltd. since 2018. He has been a Director of Potash Corporation of Saskatchewan Inc. since January 1, 2018.

CEO Compensation
  • Chuck's compensation has increased whilst company is loss making.
  • Chuck's remuneration is higher than average for companies of similar size in Canada.
Management Team Tenure

Average tenure and age of the Nutrien management team in years:

0.3
Average Tenure
51
Average Age
  • The average tenure for the Nutrien management team is less than 2 years, this suggests a new team.
Management Team

Chuck Magro

TITLE
President
COMPENSATION
$13M
AGE
48
TENURE
1.8 yrs

Fred Thun

TITLE
Senior Vice President of Finance
COMPENSATION
$3M
TENURE
0.3 yrs

Mike Frank

TITLE
Executive VP & CEO of Retail
COMPENSATION
$4M
AGE
54

Pedro Farah

TITLE
Executive VP & CFO
TENURE
0.2 yrs

Brent Poohkay

TITLE
Executive VP & Chief Information Officer
AGE
48

Mike Webb

TITLE
Executive VP and Chief Human Resources & Administrative Officer

Richard Downey

TITLE
Vice President of Investor & Corporate Relations

Joseph Podwika

TITLE
Executive VP & Chief Legal Officer
AGE
55

Kevin Graham

TITLE
Executive VP & President of Sales
AGE
40

Leslie O'Donoghue

TITLE
Executive VP and Chief Strategy & Corporate Development Officer
AGE
55
Board of Directors Tenure

Average tenure and age of the Nutrien board of directors in years:

1.3
Average Tenure
59.5
Average Age
  • The average tenure for the Nutrien board of directors is less than 3 years, this suggests a new board.
Board of Directors

Derek Pannell

TITLE
Non-Executive Chairman
COMPENSATION
$362K
AGE
71
TENURE
0.5 yrs

Chuck Magro

TITLE
President
COMPENSATION
$13M
AGE
48
TENURE
1.3 yrs

Maura Clark

TITLE
Director
COMPENSATION
$281K
AGE
59
TENURE
1.3 yrs

Keith Martell

TITLE
Director
COMPENSATION
$276K
AGE
55
TENURE
1.3 yrs

Mayo Schmidt

TITLE
Director
COMPENSATION
$270K
AGE
60
TENURE
1.3 yrs

John Estey

TITLE
Director
COMPENSATION
$271K
AGE
67
TENURE
1.3 yrs

Dave Everitt

TITLE
Director
COMPENSATION
$266K
AGE
66
TENURE
1.3 yrs

Russ Girling

TITLE
Director
COMPENSATION
$264K
AGE
55
TENURE
1.3 yrs

Jerry Grandey

TITLE
Director
COMPENSATION
$264K
AGE
71
TENURE
1.3 yrs

Miranda Hubbs

TITLE
Director
COMPENSATION
$266K
AGE
52
TENURE
1.3 yrs
Who owns this company?
Recent Insider Trading
  • Nutrien insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
04. Mar 19 Sell Robert Kirkpatrick Individual 01. Mar 19 01. Mar 19 -500 CA$72.35 CA$-36,173
14. Feb 19 Sell Derek Pannell Individual 14. Feb 19 14. Feb 19 -6,221 CA$71.55 CA$-445,123
10. Jan 19 Buy Aaron Regent Individual 27. Dec 18 27. Dec 18 7,900 CA$63.43 CA$501,097
14. Dec 18 Buy Michael Webb Individual 14. Dec 18 14. Dec 18 1,000 CA$63.29 CA$63,293
19. Dec 18 Sell Robert Kirkpatrick Individual 09. Nov 18 09. Nov 18 -1,500 CA$75.25 CA$-112,875
20. Aug 18 Sell Keith Martell Individual 17. Aug 18 17. Aug 18 -500 CA$73.26 CA$-36,631
03. Aug 18 Sell Steven Douglas Individual 03. Aug 18 03. Aug 18 -25,000 CA$73.95 CA$-1,848,747
12. Jun 18 Sell Steven Douglas Individual 12. Jun 18 12. Jun 18 -15,000 CA$68.63 CA$-1,029,486
01. Jun 18 Buy Aaron Regent Individual 31. May 18 31. May 18 15,200 CA$65.77 CA$999,704
10. May 18 Sell Steven Douglas Individual 09. May 18 09. May 18 -15,750 CA$62.93 CA$-991,147
09. May 18 Buy Michael Webb Individual 09. May 18 09. May 18 3,000 CA$63.43 CA$190,277
X
Management checks
We assess Nutrien's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Nutrien has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

NTR News

Simply Wall St News

Did Nutrien Ltd (TSE:NTR) Create Value For Investors Over The Past Year?

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it is important. … Another way to think of that is that for every CA$1 worth of equity in the company, it was able to earn CA$0.027. … Return on Equity = Net Profit ÷ Shareholders' Equity

Simply Wall St -

Nutrien Ltd (TSE:NTR): What Are Investors Earning On Their Capital?

and want a simplistic look at the return on Nutrien Ltd (TSE:NTR) stock. … Your return is tied to NTR’s ability to do this because the amount earned is used to invest in opportunities to grow the business or payout dividends, which are the two sources of return on investment. … Thus, to understand how your money can grow by investing in Nutrien, you need to look at what the company returns to owners for the use of their capital, which can be done in many ways but today we will use return on capital employed (ROCE)

Simply Wall St -

Is Nutrien Ltd (TSE:NTR) A Good Dividend Stock?

In the past, Nutrien Ltd (TSE:NTR) has returned an average of 2.00% per year to investors in the form of dividend payouts. … 5 questions I ask before picking a dividend stock … If you are a dividend investor, you should always assess these five key metrics:

Simply Wall St -

How Did Nutrien Ltd's (TSE:NTR) 0.20% ROE Fare Against The Industry?

The content of this article will benefit those of you who are starting to educate yourself about investing in the stock market. … and want a simplistic look at the return on Nutrien Ltd (TSE:NTR) stock. … Nutrien Ltd (TSE:NTR) generated a below-average return on equity of 0.20% in the past 12 months, while its industry returned 8.83%.

Simply Wall St -

What Are Analysts Saying About Nutrien Ltd's (TSE:NTR) Profit Margin?

As analysts forecast … Nutrien Ltd (TSE:NTR) to … earnings growth of 33.93% annualised

Simply Wall St -

Should You Be Concerned With Nutrien Ltd's (TSE:NTR) -79.57% Earnings Drop?

View our latest analysis for Nutrien Was NTR's recent earnings decline indicative of a tough track record? … I use the ‘latest twelve-month’ data, which annualizes the latest 6-month earnings release, or some times, the latest annual report is already the most recent financial data. … Although revenue growth in the past couple of years, has been negative, earnings growth has been deteriorating by even more, suggesting that Nutrien has been growing its expenses.

Simply Wall St -

What Should Investors Know About Nutrien Ltd's (TSE:NTR) Future Margins?

To help investors get a top level understanding, I will try to evaluate Nutrien's margin behaviour so investors can evaluate the revenue and cost drivers behind future earnings projections and understand how they may impact on returns compared to the industry. … Margin Calculation for NTR Profit Margin = Net Income ÷ Revenue ∴ Profit Margin = 47.00 Million ÷ 6.52 Billion = 0.72% There has been a contraction in Nutrien's margin over the past five years, as a result of net income declining at -28.39% on average, which was quicker than the average fall in revenue of -10.05%, meaning that the decrease in revenue has coincided with a smaller portion falling to the bottom line. … Forward looking projections suggest margins will shift towards expansion, with 8.85% in expected annual revenue growth and annual net income growth forecasted at 34.46%.

Simply Wall St -

Nutrien Ltd (TSE:NTR): Will The Growth Last?

Below, I've presented key growth figures on how market analysts predict Nutrien's earnings growth outlook over the next couple of years and whether the future looks brighter. … View our latest analysis for Nutrien Market analysts' prospects for this coming year seems buoyant, with earnings growth more than doubling. … This means that, we can presume Nutrien will grow its earnings by 41.28% every year for the next couple of years.

Simply Wall St -

Is Nutrien Ltd (TSE:NTR) Undervalued After Accounting For Its Future Growth?

Nutrien is trading at price-to-earnings (PE) ratio of 250.81x, this also tells us the stock is overvalued based on current earnings compared to the chemicals industry average of 17.97x , and overvalued compared to the CA market average ratio of 15.41x. … TSX:NTR PE PEG Gauge Apr 6th 18 We understand NTR seems to be overvalued based on its current earnings, compared to its industry peers. … This tells us that when we include its growth in our analysis Nutrien's stock can be considered overvalued , based on fundamental analysis.

Simply Wall St -

What does Nutrien Ltd's (TSE:NTR) Balance Sheet Tell Us About Its Future?

At this constant level of debt, the current cash and short-term investment levels stands at US$116.00M for investing into the business. … On top of this, NTR has generated cash from operations of US$1.23B over the same time period, resulting in an operating cash to total debt ratio of 27.58%, meaning that NTR’s current level of operating cash is high enough to cover debt. … Next Steps: NTR’s high cash coverage means that, although its debt levels are high, the company is able to utilise its borrowings efficiently in order to generate cash flow.

Simply Wall St -

NTR Company Info

Description

Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. It operates in four segments: Retail, Potash, Nitrogen, and Phosphate and Sulfate. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating 1,700 retail locations. The company was incorporated in 2017 and is headquartered in Saskatoon, Canada.

Details
Name: Nutrien Ltd.
NTR
Exchange: TSX
Founded: 2017
CA$43,377,121,761
597,481,016
Website: http://www.nutrien.com
Address: Nutrien Ltd.
122 – 1st Avenue South,
Suite 500,
Saskatoon,
Saskatchewan, S7K 7G3,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
TSX NTR Common Shares The Toronto Stock Exchange CA CAD 02. Jan 2018
NYSE NTR Common Shares New York Stock Exchange US USD 02. Jan 2018
DB N7T Common Shares Deutsche Boerse AG DE EUR 02. Jan 2018
LSE 0NHS Common Shares London Stock Exchange GB USD 02. Jan 2018
BMV NTR N Common Shares Bolsa Mexicana de Valores MX MXN 02. Jan 2018
Number of employees
Current staff
Staff numbers
5,104
Nutrien employees.
Industry
Fertilizers and Agricultural Chemicals
Materials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/24 00:59
End of day share price update: 2019/04/23 00:00
Last estimates confirmation: 2019/04/23
Last earnings filing: 2019/02/06
Last earnings reported: 2018/12/31
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.